Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.01 USD | -1.08% |
|
-2.57% | -20.63% |
25/06 | Orion Obtains License to Market Navamedic's Parkinson's Disease Drug in Europe | MT |
25/06 | Moody's Affirms Orion Ratings on Market Position, Operating Profitability | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.63% | 1.28B | |
+20.77% | 68.41B | |
-4.97% | 46.47B | |
+24.89% | 44.71B | |
+33.20% | 28.02B | |
+8.74% | 19.29B | |
+15.57% | 17.23B | |
-12.49% | 14.85B | |
-29.11% | 14.21B | |
-31.12% | 11.85B |
- Stock Market
- Equities
- OEC Stock
- News Orion S.A.
- Orion Keeps Interim Quarterly Dividend at $0.0207 a Share, Payable Oct. 9 to Shareholders of Record July 1